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COMPLEX RETINAL DETACHMENT IN
PHAKIC PATIENTS
Previtrectomy Phacoemulsiﬁcation Versus
Combined Phacovitrectomy
GIAN MARCO TOSI, MD, PHD,* ANGELO BALESTRAZZI, MD, PHD,* STEFANO BAIOCCHI, MD,*
ANTONIO TARANTELLO, MD,* GABRIELE CEVENINI, MD,† DAVIDE MARIGLIANI, MD,*
FRANCESCO SIMI, MD*
Purpose: To assess the impact of phacoemulsiﬁcation performed one week before pars
plana vitrectomy versus combined phacovitrectomy on postoperative anterior segment
status and ﬁnal functional and anatomical outcomes in phakic patients affected by complex
rhegmatogenous retinal detachment.
Methods: The authors retrospectively reviewed the records of 59 phakic patients
affected by complex rhegmatogenous retinal detachment. Twenty-nine patients underwent
cataract surgery 7 days before vitrectomy (preemptive cataract surgery—Group 1),
whereas 30 patients underwent combined phacovitrectomy (Group 2). Preoperative, intra-
operative, early- and late-postoperative outcomes were measured and compared.
Results: Numbers of previous retinal surgical procedures, nuclear sclerosis grade,
proliferative vitreoretinopathy grade, eyes with inferior breaks, surgical time, and ratio of
silicone oil/gas tamponade were all similar between the two groups. After surgery, there
was less extension of posterior synechia in Group 1. There was no signiﬁcant difference in
ﬁbrin, number of patients with posterior synechia, ﬁnal intraocular pressure, retinal
redetachment rate, ﬁnal retinal status, or ﬁnal best-corrected visual acuity.
Conclusion: Preemptive cataract surgery was associated with less extensive post-
operative posterior synechia, however, its ﬁnal functional and anatomical outcomes were
not signiﬁcantly different from those of phacovitrectomy. Both approaches were efﬁcacious.
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Pars plana vitrectomy (PPV) is often necessary torepair complex rhegmatogenous retinal detach-
ment (RRD),1–4 and lens status may determine the
anatomical success in such patients.3,5 A preexisting
cataract may limit visualization, the native lens
may limit the extent to which the vitreous can be
removed and traction relieved, and peripheral
pathology may be more difﬁcult to identify and treat
in the phakic eye.2,3,5–13
Eyes left phakic at the completion of surgery may
have a lower rate of anatomical success when compared
with eyes rendered aphakic or pseudophakic.2,3,13–16
Pars plana vitrectomy associated with silicone oil or
gas tamponade in a phakic eye leads to cataract. Oil
removal is usually performed before cataract surgery,
meaning multiple surgeries are needed in the case of
redetachment. Moreover, cataract surgery may be more
complex in the previously vitrectomized eye.17–19
Management options to render the eye nonphakic
during vitrectomy include phacofragmentation through
the pars plana (most often without intraocular lens—IOL)
and combination anterior cataract surgery (with IOL).
There are advantages to each approach.3,5,6,10–12,20–26
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An alternative is to render the eye nonphakic before
PPV (preemptive cataract surgery with IOL place-
ment). The outcomes of this last approach have not
been reported to date. We compared two groups of
patients with phakic complex RRD from the speciﬁc
view points of their postoperative anterior segment
status and ﬁnal anatomical and functional outcomes.
In the ﬁrst Group, phacoemulsiﬁcation with IOL was
performed one week before PPV (preemptive cataract
surgery), whereas in the second Group, phacoemulsi-
ﬁcation with IOL was performed with PPV in the
same sitting (combined phacovitrectomy).
Patients and Methods
We retrospectively reviewed the clinical records of
patients affected by RRD who were subjected to PPV
between January 2011 and March 2015 at the Ophthal-
mology Unit of the Department of Medicine, Surgery
and Neuroscience, University of Siena, Siena, Italy. The
research adhered to the principles of the Declaration of
Helsinki, and the institutional review board approved
the study. Patients were treated after being informed of
the nature of the treatment being offered, the potential
risks, beneﬁts, adverse effects, possible treatment out-
comes, and after having signed a consent form.
The patients included had clinical signs of primary
or recurrent chronic total or subtotal macula-involving
complex RRD (RRD extent 270° or greater, very low
mobility, rolled edges of retinal breaks, or well-
established proliferative vitreoretinopathy (PVR) with
epiretinal and/or subretinal proliferation) and had not
previously been subjected to cataract surgery.
We excluded patients with recent onset partial, sub-
total, or total phakic RRD, recent and late onset
pseudophakic or aphakic RRD, tractional diabetic retinal
detachment, RRD due to giant retinal tear, RRD related
to ocular traumas, and patients subjected to previous
intraocular surgery except vitreoretinal surgery.
Cataract surgery was performed either 1 week
(range: 6–8 days; mean: 7 days) before PPV (preemp-
tive cataract surgery—Group 1) or during the PPV
procedure (combined phacovitrectomy—Group 2). In
particular, in Group 1 cataract surgery was performed
at the time of the initial visit and PPV 6 days to 8 days
(mean: 7 days) after cataract surgery. In the combined
Group, the surgical procedure was performed between
3 and 6 days after initial diagnosis.
The patients were assigned to either Group 1 or
Group 2 based on the logistics and timing of repair, that
is, patient preference, available operating room time, etc.
Phacoemulsiﬁcation was performed by one of three
surgeons (A.B., S.B. or G.M.T.) in both Groups.
Vitrectomy was performed by the same surgeon (G.
M.T.) assisted by a vitreoretinal fellow.
The cataract procedure, the IOL inserted (aspheric,
hydrophobic acrylic, foldable, one-piece IOL [AcrySof
SA60AT; Alcon Inc, Fort Worth, TX]), and the
phacoemulsiﬁcation machine (Inﬁniti Vision System;
Alcon Inc), were identical in Group 1 and Group 2. The
cataract wound was sutured in every patient in both
Groups. No intracameral steroids were used at the
conclusion of the cataract surgery in either Group.
Intraocular lens calculation was based on the biometric
ﬁndings and anteroposterior globe measurements of
both eyes, as well as the opposite eye refraction.
In patients who underwent preemptive cataract
surgery, a posterior capsulectomy was not performed
at the time of PPV.
Encircling scleral buckling was associated with PPV
in all patients using a 41 band. For the patients who
had previously been subjected to scleral buckling for
RRD, no scleral buckling revision was performed. In
both Groups, extensive 3-port 20- or 23-gauge PPV
was performed using the Stellaris PC (Bausch and
Lomb, Rochester, NY) and a panoramic contact
viewing system (Advanced Visual Instruments, Inc,
New York, NY). Twenty-gauge PPV was chosen
because of the temporary absence of appropriate
instrumentation for bimanual membrane dissection in
small-gauge PPV. Epiretinal membrane peeling and
retinotomy were performed when necessary and
appropriate. Intraocular tamponade was achieved with
either silicone oil 1000 cSt or gas (C3F8 13%).
Silicone oil was used if the patient was monocular;
when maintaining prone positioning was too difﬁcult;
when a retinotomy of more than 90° was required; and
at the discretion of the operating surgeon.
Postoperative management after preemptive cataract
surgery consisted of the topical instillation of tobramycin–
dexamethasone four times daily, moxiﬂoxacin three times
daily, and bromfenac twice daily, up to the day of the
PPV procedure.
Postoperative management after PPV for both Groups
consisted of the topical instillation of tobramycin–
dexamethasone four times daily, bromfenac twice
daily, and cyclopentolate twice daily.
Preoperative data were reviewed together with
postoperative data from days 1, 7, 15, and 22, and
months 1, 2, 3, and 6. For eyes with longer follow-up
periods, subsequent information was also reviewed.
The following preoperative variables were identiﬁed:
patient age/sex, number and type of previous retinal
surgeries, best-corrected visual acuity, anterior segment
status, intraocular pressure (IOP), and RRD character-
istics. In particular, we recorded the corneal endothelial
cell count, degree of nuclear sclerosis (graded from 1 to
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4), location of retinal breaks, and extent of PVR
(updated PVR classiﬁcation).27 For the intergroup
comparison of preoperative retinal status, we divided
the PVR grade C into two subgroups, the ﬁrst lower
than C6 and the second equal to or greater than C6.
The intraoperative information recorded included
phacoemulsiﬁcation- or PPV-associated complica-
tions, PPV surgical time, type of PPV (noncannulated
20 gauge or protected 23 gauge), PPV-associated
procedures (scleral buckle and PVR removal), and
postoperative tamponade.
Postoperative outcomes were divided into early
postoperative (ﬁrst 6 months after surgery) and late
postoperative (more than 6 months after surgery). The
early postoperative outcomes were presence of cor-
neal edema, ﬁrst postoperative day IOP, use of IOP-
lowering medication in the ﬁrst 3 weeks after PPV,
formation of ﬁbrin and posterior synechia, extent of
posterior synechia, occurrence of IOL dislocation,
occurrence of pupillary block, occurrence of optic/iris
capture, and whether postoperative prone positioning
was recommended. In the early postoperative period,
IOP-lowering medications were initiated if the IOP
was above 25 mmHg. Each topical antiglaucoma
medication was given a score of 1, and an additional
1 point was calculated if a systemic anhydrase
inhibitor was added. Fibrin in the anterior chamber
was documented by its presence or absence, without
grading its severity. The extent of posterior synechia
was noted and documented after dilatation of the pupil
with tropicamide, according to the extent of pupillary
margin involvement (less than 90° [1 point], between
90° and 180° [2 points], between 180° and 270°
[3 points], and more than 270° [4 points]).
The late postoperative outcomes included ﬁnal IOP
including the number of patients with hypotony (IOP
# 5 mmHg); patients on IOP-lowering medications to
maintain an IOP# 20 mmHg; number of patients with
posterior synechia and extent of posterior synechia;
number of patients with optic iris capture; cystoid
macular edema; occurrence of postoperative macular
epiretinal membrane; recurrence of retinal detachment
and its cause; number of patients with oil in the eye at
last follow-up; ﬁnal best-corrected visual acuity; and
ﬁnal refractive status.
Statistical Analysis
Group comparisons were performed using the
Student’s t-test for quantitative continuous variables;
the nonparametric test of medians for quantitative dis-
crete variables; and the Fisher exact test (applied
to contingency tables) for qualitative variables. A
Bonferroni correction of the P value was not used
because only one comparison (between the two
Groups) was performed for each variable. A statistical
signiﬁcance level of 95% was used for all computa-
tions (P = 0.05).
Results
Demographics
After the application of inclusion and exclusion
criteria, 73 patients were identiﬁed. Fourteen patients
were unable to attend the follow-up visit and were not
included in the study. A total of 59 eyes of 59 subjects
participated in the study. The mean age was 64.8 ±
10.4 years; 37 patients were male and 22 were female.
Twenty-nine eyes constituted Group 1 (preemptive
cataract surgery) and 30 eyes constituted Group 2
(combined phacovitrectomy Group). Follow-up
ranged from 9 months to 48 months in Group 1 (mean
21.1 months) and from 9 to 48 months in Group 2
(mean 23.6 months) (P = 0.412).
Entry and Intraoperative Findings
At entry, a signiﬁcantly worse best-corrected visual
acuity was found in Group 1 compared with Group 2
(P , 0.001) (Table 1). One patient had a posterior
capsular break in the preemptive cataract surgery
Group (3.4%), whereas no patient had a posterior cap-
sular break in the combined Group. In the patient with
capsular break, the IOL was implanted in the capsular
bag and the patient underwent PPV 7 days later,
receiving C3F8 13% as a postoperative tamponade,
without developing postoperative posterior synechia
or IOL dislocation. No patient required the use of iris
retractors in Group 1, whereas 2 patients required the
use of iris retractors in Group 2 because of sudden
intraoperative myosis during the phacoemulsiﬁcation
procedure (P = 0.364). No other complication was
encountered during phacoemulsiﬁcation and the PPV
procedure in either Group. In Group 1, ﬁve patients
required retinotomy (17.2%), whereas in Group 2, four
patients required retinotomy (13.3%) (P = 0.731).
Early Postoperative Findings
No patients in either Group experienced corneal
edema on postoperative day 1 (Table 2). The ﬁrst post-
operative day IOP was signiﬁcantly lower in Group 1
(25.66 ± 5.7 mmHg) compared with Group 2 (29.77 ±
7.6 mmHg) (P = 0.022), as was the mean number of
IOP-lowering medications at Week 1 (P = 0.005), 2
(P = 0.003), and 3 (P = 0.035) after surgery. Fibrin
formation was lower in Group 1, although not signiﬁ-
cantly, (1 of 29 eyes [3.4%]) compared with Group 2
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(6 of 30 eyes [20%]) (P = 0.103). No signiﬁcant
between-group difference was found in terms of the
number of patients with posterior synechia (3 of 29
in Group 1 [10.3%] and 7 of 30 in Group 2 [23.3%])
(P = 0.118), whereas the extension of posterior syne-
chia was lower in Group 1 (P = 0.019). In fact, a total of
4 quadrants of pupillary margin were involved in Group
1, whereas a total of 14 quadrants were involved in
Group 2. The 2 patients who needed iris retractors in
Group 2 did not develop ﬁbrin but did develop posterior
synechia. Among the 6 patients in Group 2 who showed
ﬁbrin, 4 developed posterior synechia; the 1 patient in
Group 1 showing ﬁbrin did not develop posterior syn-
echia. No patients in either Group experienced IOL
dislocation, optic/iris capture, or pupillary block.
Late Postoperative Findings
No signiﬁcant differences were found between
Groups 1 and 2 in terms of ﬁnal IOP (P = 0.560) (Table
3). With reference to the 3 hypotony patients (1 in
Group 1 and 2 in Group 2), the 2 patients in Group 2
showed ﬁbrin formation and developed 3 and 4 quad-
rants of posterior synechia, respectively. Neither of
these two showed recurrent RRD. The patient in Group
1 did not develop ﬁbrin nor posterior synechia but
suffered recurrent retinal detachment from PVR.
All the recurrences of RRD (1 in Group 1 and 3 in
Group 2) were related to PVR; none of the patients
with recurrent RRD showed postoperative ﬁbrin or
posterior synechia.
Discussion
In complex retinal detachment, eyes managed with
PPV and left phakic at the completion of surgery may
have a lower rate of anatomical success compared with
eyes rendered aphakic or pseudophakic.3,14–16 Even in
uncomplicated RRD, although the results are not
always conclusive,4,28 Orlin et al13 and Caiado et al2
found a signiﬁcantly increased redetachment rate in
Table 1. Entry and Intraoperative Variables of Group 1 Patients (Preemptive Cataract Surgery) and of Group 2 Patients
(Combined Phacovitrectomy)
Group 1 (29 Patients) Group 2 (30 Patients) P
Sex, n (%) 0.288
Male 16 (55.2) 21 (70)
Female 13 (44.8) 9 (30)
Mean age 66.2 ± 9.9 63.9 ± 10.3 0.385
Previous surgery, n (%) 4 (13.8) 7 (23.3) 0.506
Entrance VA, n (%) 0.001
CF 2 (6.9) 21 (70)
HM 22 (75.8) 7 (23.3)
LP 5 (17.2) 2 (6.6)
Mean preop IOP, mmHg 15 ± 3 13.8 ± 4.7 0.244
Nuclear sclerosis, n (%) 0.989
Grade 1 12 (41.3) 13 (43.3)
Grade 2 13 (44.8) 13 (43.3)
Grade 3 4 (13.8) 4 (13.3)
Inferior breaks 14 (48.2) 15 (50) 1.000
PVR grade, n (%) 0.296
A 6 (20.6) 10 (33.3)
B 11 (37.9) 12 (40)
,C6 7 (24.1) 7 (23.3)
$C6 5 (17.2) 1 (3.3)
PPV caliper, n (%) 0.748
20 G 5 (17.2) 7 (23.3)
23 G 24 (82.8) 23 (76.6)
Need for iris retractors during PPV, n
(%)
0 (0) 2 (6.6) 0.364
Retinotomy, n (%) 5 (17.2) 4 (13.3) 0.731
Tamponade, n (%) 1.000
Silicone oil 14 (48.2) 15 (50)
Gas 15 (51.7) 15 (50)
Mean surgical time, minutes 178.5 ± 34.4 176.9 ± 27.7 0.816
Posterior capsule break, n (%) 1 (3.4) 0 (0) 0.246
CF, count ﬁngers; HM, hand motion; LP, light perception; VA, visual acuity.
Statistically signiﬁcant values are in italics.
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phakic compared with pseudophakic/aphakic eyes. In
addition, Caiado et al2 demonstrated the importance of
combined phacovitrectomy in relation to improved
outcomes in RRD repair, with success rates similar
to primary PPV in pseudophakic eyes. Both Orlin
et al13 and Caiado et al2 hypothesized more extensive
vitreous removal to be the major reason for increased
reattachment rates in pseudophakic or aphakic PPV
compared with phakic PPV. They included patients
without PVR13 or with a PVR grade of up to CP1.2
Management options to render the eye nonphakic
during vitrectomy include combination anterior
Table 3. Late Postoperative Variables of Group 1 Patients (Preemptive Cataract Surgery) and of Group 2 Patients
(Combined Phacovitrectomy)
Group 1 (29 Patients) Group 2 (30 Patients) P
Final IOP, n (%) 0.560
Norm 26 (89.6) 24 (80)
Hypo 1 (3.4) 2 (6.6)
Hyper 2 (6.8) 4 (13.3)
Posterior synechia 3 (10.3) 7 (23.3) 0.118
Synechia extension among patients
with posterior synechia, n (%)
0.019
0°–90° 2 (66.6) 3 (42.8)
90°–180° 1 (33.3) 2 (28.5)
180°–270° 0 (0) 1 (14.2)
270°–360° 0 (0) 1 (14.2)
Optic/iris capture 0 0 1.000
CME, n (%) 0 (0) 0 (0) 1.000
ERM, n (%) 7 (24.1) 4 (13.3) 0.333
Recurrent RRD, n (%) 1 (3.4) 3 (10) 0.483
Recurrence due to PVR, n (%) 1 (100) 3 (100) 0.483
Final retinal reattachment, n (%) 29 (100) 30 (100) 1.000
Eyes with permanent silicone oil, n
(%)
1 (3.4) 1 (3.3) 0.746
Mean ﬁnal BCVA, logMAR 0.42 ± 0.65 0.45 ± 0.63 0.859
Mean refractive status 21.86 ± 0.75 21.99 ± 1.59 0.687
BCVA, best-corrected visual acuity; CME, cystoid macular edema; ERM, epiretinal membrane.
Statistically signiﬁcant values are in italics.
Table 2. Early Postoperative Variables of Group 1 Patients (Preemptive Cataract Surgery) and of Group 2 Patients
(Combined Phacovitrectomy)
Group 1 (29 Patients) Group 2 (30 Patients) P
Corneal edema 0 0 1.000
Mean postop IOP (Day 1), mmHg 25.6 ± 5.7 29.7 ± 7.6 0.022
Mean no. postop antiglaucoma
medications (Week 1)
0.62 ± 0.7 1.23 ± 0.9 0.005
Mean no. postop antiglaucoma
medications (Week 2)
0.37 ± 0.7 1.16 ± 1.2 0.003
Mean no. postop antiglaucoma
medications (Week 3)
0.24 ± 0.5 0.76 ± 1.2 0.035
Prone position, n (%) 14 (48.2) 15 (50) 1.000
Fibrin, n (%) 1 (3.4) 6 (20) 0.103
Posterior synechia, n (%) 3 (10.3) 7 (23.3) 0.118
Synechia extension among patients
with posterior synechia, n (%)
0.019
0°–90° 2 (66.6) 3 (42.8)
90°–180° 1 (33.3) 2 (28.5)
180°–270° 0 (0) 1 (14.2)
270°–360° 0 (0) 1 (14.2)
IOL dislocation 0 0 1.000
Pupillary block 0 0 1.000
Optic/iris capture 0 0 1.000
Statistically signiﬁcant values are in italics.
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cataract surgery and phacofragmentation through the
pars plana.
Phacofragmentation, by removing the potential
scaffold for reproliferation constituted by the lens
and the capsule, is reserved primarily for advanced
PVR with a signiﬁcant anterior component.3,5
Combination cataract surgery (with IOL) with
vitrectomy (combined phacovitrectomy) affords
enhanced access to and management of the anterior
pathology when compared with phakic vitrectomy.
However, combined phacovitrectomy may lead to
anterior segment complications such as optic/iris
capture, posterior synechia, capsular phimosis, and
secondary pupillary block.3,5,6,10,12,20,21 This develop-
ment may be due to the displacement of the lens ante-
riorly from the vitreous tamponade, possibly in
combination with an inﬂammatory response after vit-
rectomy and endophotocoagulation.3,5 After com-
bined phacovitrectomy, the anterior segment
outcomes reported in the literature are variable,
including up to 55.8% of patients with elevated
IOP,6,14,18,21 between 4% and 22% with ﬁbrin forma-
tion,6,18 between 7% and 30% with posterior syne-
chia,11,18 and up to 33% with posterior capsule
opaciﬁcation.6,10,20,26 In addition, in case the vitreor-
etinal surgeon does not perform the cataract surgery,
combined phacovitrectomy requires two surgeons,
thus becoming logistically challenging.
An alternative is to render the eye nonphakic before
PPV. Preemptive cataract surgery performed before
planned vitreous surgery, although submitting the
patient to two separate surgeries in a short period,
may diminish the risk of these anterior segment/IOL
complications, whereas maintaining the advantages of
a pseudophakic vitrectomy. Rendering the eye pseu-
dophakic 1 week before surgery may limit the degree
of postvitrectomy inﬂammation and may allow the
IOL to “sit ﬁrmly” in the capsule, thus limiting the risk
of optic prolapse and capture.
To this end, we compared patients treated with
phacoemulsiﬁcation before PPV to patients who
underwent combined phacovitrectomy. The 7-day time
lapse between cataract surgery and PPV aimed to
reduce anterior segment reaction without signiﬁcantly
postponing RRD surgery, possibly limiting further
retinal damage.
We would have expected a longer surgical time in
the combined group, however, no signiﬁcant differ-
ence was encountered. This might be explained by the
fact that cataract surgery is relatively brief, in an
otherwise long surgical procedure because of the
severity of preoperative retinal status, which in our
custom is addressed with a meticulous vitreous
removal and the placement of an encircling band.
The anatomical and functional outcomes after the
surgical repair of these complex retinal detachments
were similar between the Groups, perhaps because the
retinal surgery was performed within the same relative
period. All RRD recurrences were due to PVR; in
particular, the recurrence rate was higher in the
combined Group, although this was not statistically
signiﬁcant. In addition, the number of secondary
macular epiretinal membranes was higher in the pre-
emptive cataract Group; again, this was not signiﬁcant.
One patient in each Group required permanent silicone
oil tamponade as a consequence of severe hypotony.
The anticipated purpose of preemptive cataract sur-
gery was to reduce anterior segment inﬂammatory and
mechanical complication rates after PPV with an
extended vitreous tamponade. Fibrin formation and the
number of patients with posterior synechia were higher
in the combined Group, although not signiﬁcantly. The
extension of posterior synechia was signiﬁcantly greater
in the combined Group. This occurred in the absence of
between-group differences in prone positioning. Metic-
ulous vitreous removal was possible without the need
for iris retractors in the preemptive cataract surgery
Group, whereas two patients in the phacovitrectomy
Group required iris retractors. These two patients
developed posterior synechia. The absence of post-
operative use of short acting mydriatics, which have
been shown to reduce the incidence of posterior
synechia, could have impacted our posterior synechia
ﬁndings.11,12 However, the topically prescribed regimen
was the same in both Groups. The slightly increased
anterior segment inﬂammatory response in the com-
bined Group may have been partially responsible for
the early postoperative IOP ﬁndings. In fact, the phaco-
vitrectomy Group showed a signiﬁcantly higher ﬁrst day
postoperative IOP.
The fact that cell and ﬂare were not evaluated and
ﬁbrin and posterior synechia were not quantitatively
measured constitute limitations of this study. More-
over, the retrospective nature of the study and the
lack of randomization in relation to the type of
treatment constitute a bias. However, as previously
noted, patient allocation to either preemptive or
concurrent cataract surgery was based on logistical
concerns (see Patients and Methods), and, in our
opinion, had no effect on our results. In fact, because
no signiﬁcant between-group differences were
encountered in sex, age, PVR grade, number of
patients with inferior breaks, nuclear sclerosis, pre-
operative IOP, 20-gauge/23-gauge ratio, oil/gas ratio,
surgical time, number of previous retinal surgeries, or
number of patients who required prone positioning
postoperatively, and because best-corrected visual
acuity at entry, although signiﬁcantly different
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between Groups, was no better than count ﬁngers in
either Group, the above-mentioned limitations may
be considered of minor importance.
The peculiarities of this study are represented by the
surgical approach/timing, which has never been re-
ported so far, and by the select subcohort of patients
affected by high-risk RRD. Preemptive cataract sur-
gery in the management of phakic patients with
complex RRD seems to at least slightly reduce the
postoperative inﬂammatory component when com-
pared with combined phacovitrectomy. However, in
the present series, the two approaches had no signif-
icantly different ﬁnal anatomical or functional out-
comes. Both approaches were efﬁcacious.
Key words: complex rhegmatogenous retinal
detachment, pars plana vitrectomy, preemptive cata-
ract surgery, combined phacovitrectomy, intraocular
inﬂammation.
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